Envoy Medical (COCH) Non-Current Debt (2024 - 2025)
Envoy Medical recorded quarterly Non-Current Debt of $27.9 million in Q2 2025, up 20.89% quarter-over-quarter from $23.1 million in Q1 2025, and up 1017.28% year-over-year from $2.5 million in Q2 2024.
Envoy Medical's Non-Current Debt history runs 2 years deep, the most recent figure standing at $27.9 million for Q2 2025.
- In Q2 2025, Non-Current Debt rose 1017.28% year-over-year to $27.9 million; the TTM figure through Jun 2025 stood at $27.9 million (up 1017.28% YoY), while the FY2024 annual figure was $9.3 million, changed N/A from the prior year.
- Non-Current Debt came in at $27.9 million for Q2 2025 at Envoy Medical, up from $23.1 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $27.9 million in Q2 2025 to a low of $2.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Envoy Medical | 48.11 Mn | 22.86 Mn | -274,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 27.93 Mn |
| Jun 30, 2025 | 27.93 Mn |
| Mar 31, 2025 | 23.11 Mn |
| Mar 31, 2025 | 23.11 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Sep 30, 2024 | 14.36 Mn |
| Sep 30, 2024 | 14.36 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.50 Mn |